Introduction Results
To compare the prevalence and potential cross-reactivity of IGF1R-aAB and IR-aAB.
Recombinant variants of both receptors were stably expressed in HEK293 cells and used to establish two diagnostic aAB assays, one of which having been described recently (1). Therefore firefly luciferase was fused Cterminal to the IR or IGF1R respectively.
Autoantibodies (aAB) are characteristic of autoimmune diseases, but may also be found in apparently healthy individuals and precede pathological symptoms. We have recently reported on aAB against the IGF1-receptor (IGF1R-aAB) in control subjects and patients with Graves' disease (1). The isolated aAB were able to immunoprecipitate the recombinant autoantigen and antagonized IGF1 signaling in vitro. Given the structural similarities between IGF1R and insulin receptor (IR), we decided to establish a diagnostic test for IR-aAB similar to our IGF1R aAB assay. IR-aAB are of endocrine importance as they may cause insulin resistance type B. Up to now, there is no such test available for routine testing, despite some radioactive and cumbersome assays (2). There are thus no data on the prevalence of aAB to the insulin and IGF-1 receptor in the normal population or in diseased individuals. For this reason, we decided to establish a suitable non-radioactive test system for the detection and quantification of these aAB and to evaluate the prevalence of these aAB in human sera.
A total number of 207 samples from a commercial supplier were analyzed for IGF1R-aAB and IR-aAB. Ethical approval and a written consent from each blood donor had been maintained before starting the analyses. A comparable number of sera turned out to be positive for IGF1R-aAB and IR-aAB, respectively, with a prevalence of approx. 5% each. A fraction of positive samples turned out to react with both the IGF1R and the IR. This result either indicates the presence of multiple specific-aAB isoforms or of one type of cross-reacting aAB in a given human serum sample. Cell extracts of IR-or IGF1R-Luc fusion proteins were prepared and used for incubation with patient serum. If serum contained aAB to the receptor fusion protein (containing the endogenous autoantigen IR or IGF1R), the antigen-antibody complex was bound and precipitated by a protein-A matrix (PA). Unbound components were removed and nonspecific binding was reduced by repeated washing and centrifugation. The precipitate obtained was detected by a CT luminometer using a luciferase-specific substrate. The relative light units (RLU) obtained were directly proportional to the concentration of aAB in the human serum sample.
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